TELA Bio, Inc. (TELA) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
the bull case· 1
4
disclosed supplier and customer ties in SEC filings
sec filingsedgarthe bear case· 4
43
managers reporting a position in thirteen F filings
13fJun 30 '266
managers whose positions together make up four fifths of reported value
13fJun 30 '267 of 22
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '26−0.32%
change in shares held by the ten largest reporting managers last quarter
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 16 '26 report. Not a forecast, not advice.
TELA Bio, Inc. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 3841, Surgical & Medical Instruments & Apparatus, from each company's own filings. Largest first.
tall tick = annual report · 1 on record
TELA (TELA Bio, Inc.) has 3 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
High 1.30 at 10:45 am ET, low 1.18 at 1:00 pm ET.
TELA Bio, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Surgical & Medical Instruments & Apparatus
43 managers report a position worth $19.3M between them, and 6 of them hold 80% of it.